Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Anal Biochem ; 382(1): 66-8, 2008 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-18675772

RESUMEN

Monoclonal antibodies are a major subclass of biopharmaceuticals. They are structurally different from other biopharmaceuticals in size and quaternary structure. Here we demonstrate a correlation between chemical stability of antibodies and thermal stability. We show that overall thermal protein stability can be predicted based on the measurement of free sulfhydryl (-SH) content on applying mildly denaturing conditions. We propose that this method can be adapted to a high-throughput screening format and used either as an absolute measure of thermal stability or for ranking a panel of possible variants.


Asunto(s)
Anticuerpos Monoclonales/química , Compuestos de Sulfhidrilo/análisis , Compuestos de Sulfhidrilo/química , Animales , Anticuerpos Monoclonales/metabolismo , Calibración , Bovinos , Fluorescencia , Humanos , Desnaturalización Proteica , Temperatura de Transición
2.
Cell Immunol ; 248(2): 103-14, 2007 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-18048020

RESUMEN

Toll-like receptors are a family of pattern-recognition receptors that contribute to the innate immune response. Toll-like receptor 3 (TLR3) signals in response to foreign, endogenous and synthetic ligands including viral dsRNA, bacterial RNA, mitochondrial RNA, endogenous necrotic cell mRNA and the synthetic dsRNA analog, poly(I:C). We have generated a monoclonal antibody (mAb CNTO2424) that recognizes the extracellular domain (ECD) of human TLR3 in a conformation-dependent manner. CNTO2424 down-regulates poly(I:C)-induced production of IL-6, IL-8, MCP-1, RANTES, and IP-10 in human lung epithelial cells. In addition, mAb CNTO2424 was able to interfere with the known TLR3-dependent signaling pathways, namely NF-kappaB, IRF-3/ISRE, and p38 MAPK. The generation of this neutralizing anti-TLR3 mAb provides a unique tool to better understand TLR3 signaling and potential cross-talk between TLR3 and other molecules.


Asunto(s)
Anticuerpos Monoclonales , Receptor Toll-Like 3/antagonistas & inhibidores , Receptor Toll-Like 3/inmunología , Animales , Anticuerpos Bloqueadores/metabolismo , Anticuerpos Monoclonales/metabolismo , Sitios de Unión de Anticuerpos , Línea Celular , Línea Celular Transformada , Femenino , Humanos , Ratones , Ratones Endogámicos BALB C , Proyectos Piloto , Receptor Toll-Like 3/metabolismo
3.
Int Immunopharmacol ; 6(4): 647-55, 2006 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-16504928

RESUMEN

The incidence of pure red cell aplasia (PRCA) in patients with chronic kidney disease associated with the subcutaneous (s.c.) administration of epoetin alfa (EPREX) began to increase in 1998. As part of an intensive investigation into the reasons for this increase, in vivo models were developed to assess the ability of potential causative factors to stimulate an immune response to recombinant human erythropoietin (rHuEPO). It was difficult to generate anti-EPO antibodies in mice. In animals injected with rHuEPO alone, anti-EPO antibodies were either absent or present at very low levels. The addition of an adjuvant to the immunization protocol was able to increase both the frequency of occurrence and titer of the immune response and resulted in the generation of anti-EPO antibodies that, in most cases, recognized both human and mouse EPO. Some mice exhibited a reduction in hematocrit, suggesting neutralization of endogenous EPO by anti-EPO antibodies. To evaluate the primary lead identified in the technical investigation, leachates from the uncoated syringe stoppers of EPREX syringes, a surrogate antigen (chicken egg albumin, OVA) was used to avoid possible interferences that could arise from the use of an endogenous protein like EPO. These leachates yielded a positive, concentration-dependent antibody response in the OVA animal model, demonstrating their adjuvant properties and providing support for the hypothesis generated through the technical investigation that leachates were capable of enhancing the immune response to rHuEPO.


Asunto(s)
Eritropoyetina/inmunología , Adyuvantes Inmunológicos/farmacología , Animales , Embalaje de Medicamentos , Ensayo de Inmunoadsorción Enzimática , Humanos , Masculino , Ratones , Modelos Inmunológicos , Ovalbúmina/inmunología , Proteínas Recombinantes , Aplasia Pura de Células Rojas/inmunología , Jeringas
4.
Biochem J ; 387(Pt 3): 727-35, 2005 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-15579134

RESUMEN

Gas6 (growth-arrest-specific gene 6) is a vitamin K-dependent protein known to activate the Axl family of receptor tyrosine kinases. It is an important regulator of thrombosis and many other biological functions. The C-terminus of Gas6 binds to receptors and consists of two laminin-like globular domains LG1 and LG2. It has been reported that a Ca2+-binding site at the junction of LG1 and LG2 domains and a hydrophobic patch at the LG2 domain are important for receptor binding [Sasaki, Knyazev, Cheburkin, Gohring, Tisi, Ullrich, Timpl and Hohenester (2002) J. Biol. Chem. 277, 44164-44170]. In the present study, we developed a neutralizing human monoclonal antibody, named CNTO300, for Gas6. The antibody was generated by immunization of human IgG-expressing transgenic mice with recombinant human Gas6 protein and the anti-Gas6 IgG sequences were rescued from an unstable hybridoma clone. Binding of Gas6 to its receptors was partially inhibited by the CNTO300 antibody in a dose-dependent manner. To characterize further the interaction between Gas6 and this antibody, the binding kinetics of CNTO300 for recombinant Gas6 were compared with independently expressed LG1 and LG2. The CNTO300 antibody showed comparable binding affinity, yet different dependence on Ca2+, to Gas6 and LG1. No binding to LG2 was detected. In the presence of EDTA, binding of the antibody to Gas6 was disrupted, but no significant effect of EDTA on LG1 binding was evident. Further epitope mapping identified a Gas6 peptide sequence recognized by the CNTO300 antibody. This peptide sequence was found to be located at the LG1 domain distant from the Ca2+-binding site and the hydrophobic patch. Co-interaction of Gas6 with its receptor and CNTO300 antibody was detected by BIAcore analysis, suggesting a second receptor-binding site on the LG1 domain. This hypothesis was further supported by direct binding of Gas6 receptors to an independently expressed LG1 domain. Our results revealed, for the first time, a second binding site for Gas6-receptor interaction.


Asunto(s)
Anticuerpos Monoclonales/química , Péptidos y Proteínas de Señalización Intercelular/química , Secuencia de Aminoácidos , Sitios de Unión , Calcio/química , Mapeo Epitopo , Humanos , Cinética , Datos de Secuencia Molecular , Unión Proteica , Estructura Terciaria de Proteína
5.
J Pept Sci ; 12(1): 25-32, 2006 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-15942931

RESUMEN

Novel analogs of human monocyte chemoattractant protein 1 (MCP-1) were designed, synthesized and characterized to be used as tools to generate monoclonal antibodies as potential human therapeutics. MCP-1 and three analogs were synthesized by step-wise Fmoc solid phase synthesis. After oxidation to form the two-disulfide bonds, affinity chromatography using an immobilized mouse anti-human MCP-1 monoclonal antibody (mAb) was utilized for a simple and highly effective purification procedure for the proteins. The final products were extensively characterized and compared with recombinant human MCP-1 (rhMCP-1). All proteins showed identical binding with mouse anti-human MCP-1 mAbs as measured by surface plasmon resonance. Synthetic MCP-1 and the analogs were comparable to recombinant MCP-1 in competition radio-ligand binding to CCR2 receptors on THP-1 cells, and MCP-1-induced, calcium mobilization and chemotaxis assays.


Asunto(s)
Quimiocina CCL2/síntesis química , Quimiocina CCL2/farmacología , Secuencia de Aminoácidos , Anticuerpos Monoclonales/química , Anticuerpos Monoclonales/farmacología , Unión Competitiva , Calcio/metabolismo , Línea Celular , Quimiocina CCL2/química , Quimiotaxis/efectos de los fármacos , Quimiotaxis/fisiología , Humanos , Ligandos , Datos de Secuencia Molecular , Peso Molecular , Unión Proteica , Receptores CCR2 , Receptores de Quimiocina/efectos de los fármacos , Relación Estructura-Actividad
6.
Cytokine ; 18(2): 61-71, 2002 Apr 21.
Artículo en Inglés | MEDLINE | ID: mdl-12096920

RESUMEN

We have recently reported the identification of four novel members of the interleukin-1 (IL-1) family which we designated as IL-1 homologue 1-4 (IL-1H1-4). These proteins exhibit significant sequence homology to other members of the IL-1 family. Of these homologues, only IL-1H4 (renamed IL-1F7b) was predicted to contain a propeptide domain and a caspase cleavage site. We now report that caspase-1 cleaves IL-1F7b at the predicted site to generate mature IL-1F7b. Caspase-4 was also able to process IL-1F7b, albeit inefficiently. Other caspases and Granzyme-B did not cleave IL-1F7b. Furthermore, adenovirus-mediated expression of IL-1F7b in HEK 293 cells led to in situ processing and secretion of mature IL-1F7b. In a screen to identify a potential receptor, both pro and mature IL-1F7b bound to the soluble IL-18 receptor alpha-Fc (IL-18Ralpha-Fc) but not to the soluble IL-1R-Fc or ST2R-Fc fusion proteins. Mature IL-1F7b bound to the IL-18Ralpha-Fc protein with higher affinity than the pro form, although the affinities for both proteins were significantly lower than that observed for IL-18. Consistent with this observation, only IL-18 and not IL-1F7b induced IFN-gamma production by KG1a cells. We also report that pro and mature IL-1F7b form homodimers with association constants of 4 microM and 5 nM, respectively, suggesting biological relevance to IL-1F7b processing. Finally, we have localized the expression of IL-1F7b protein in discrete cell populations including plasma cells and tumor cells. These data suggest that IL-1F7b may be involved in immune response, inflammatory diseases and/or cancer.


Asunto(s)
Caspasa 1/metabolismo , Caspasas/metabolismo , Interferón gamma/biosíntesis , Interleucina-18/metabolismo , Interleucina-1/genética , Interleucina-1/metabolismo , Receptores de Interleucina/metabolismo , Secuencia de Aminoácidos , Sitios de Unión , Línea Celular , ADN Complementario , Humanos , Subunidad alfa del Receptor de Interleucina-18 , Receptores de Interleucina-18 , Proteínas Recombinantes de Fusión/metabolismo
7.
J Biol Chem ; 278(11): 9426-34, 2003 Mar 14.
Artículo en Inglés | MEDLINE | ID: mdl-12524421

RESUMEN

Granulocyte colony-stimulating factor regulates neutrophil production by binding to a specific receptor, the granulocyte colony-stimulating factor receptor, expressed on cells of the granulocytic lineage. Recombinant forms of granulocyte colony-stimulating factor are used clinically to treat neutropenias. As part of an effort to develop granulocyte colony-stimulating factor mimics with the potential for oral bioavailability, we previously identified a nonpeptidyl small molecule (SB-247464) that selectively activates murine granulocyte colony-stimulating factor signal transduction pathways and promotes neutrophil formation in vivo. To elucidate the mechanism of action of SB-247464, a series of cell-based and biochemical assays were performed. The activity of SB-247464 is strictly dependent on the presence of zinc ions. Titration microcalorimetry experiments using a soluble murine granulocyte colony-stimulating factor receptor construct show that SB-247464 binds to the extracellular domain of the receptor in a zinc ion-dependent manner. Analytical ultracentrifugation studies demonstrate that SB-247464 induces self-association of the N-terminal three-domain fragment in a manner that is consistent with dimerization. SB-247464 induces internalization of granulocyte colony-stimulating factor receptor on intact cells, consistent with a mechanism involving receptor oligomerization. These data show that small nonpeptidyl compounds are capable of selectively binding and inducing productive oligomerization of cytokine receptors.


Asunto(s)
Receptores de Factor Estimulante de Colonias de Granulocito/química , Receptores de Factor Estimulante de Colonias de Granulocito/metabolismo , Animales , Bencimidazoles/farmacología , Células de la Médula Ósea/metabolismo , Calorimetría , Línea Celular , Dicroismo Circular , Citocinas/metabolismo , Dimerización , Relación Dosis-Respuesta a Droga , Ácido Edético/farmacología , Guanidinas/farmacología , Iones , Ligandos , Ratones , Modelos Químicos , Péptidos/química , Unión Proteica , Estructura Terciaria de Proteína , Proteínas Recombinantes de Fusión/metabolismo , Transducción de Señal , Transfección , Ultracentrifugación , Zinc
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA